Showing results (411-420 of 432) with videos related to

Sort By:
Pageof 44
Oncotarget|October 27, 2015
Aurora B kinase is a potent and selective target in MYCN-driven neuroblastomaDominik Bogen, Jun S Wei, David O Azorsa, et al.
Journal of Experimental & Clinical Cancer Research : CR|April 24, 2023
High-throughput and targeted drug screens identify pharmacological candidates against MiT-translocation renal cell carcinomaMartin Lang, Laura S Schmidt, Kelli M Wilson, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 14, 2006
LRRTM3 promotes processing of amyloid-precursor protein by BACE1 and is a positional candidate gene for late-onset Alzheimer's diseaseJohn Majercak, William J Ray, Amy Espeseth, et al.
Biorxiv : the Preprint Server for Biology|April 17, 2026
SETD5 dysfunction in human astrocytes drives IL-6-mediated neuronal impairments via the JAK/STAT signaling pathwayAngels Almenar-Queralt, Isabella R Fernandes, Janaina S de Souza, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 23, 2013
Functional genomic screening identifies dual leucine zipper kinase as a key mediator of retinal ganglion cell deathDerek S Welsbie, Zhiyong Yang, Yan Ge, et al.
Science Translational Medicine|September 10, 2020
Therapeutic responses to Roseomonas mucosa in atopic dermatitis may involve lipid-mediated TNF-related epithelial repairIan A Myles, Carlo R Castillo, Kent D Barbian, et al.
Plos One|August 10, 2022
A humanized nanobody phage display library yields potent binders of SARS CoV-2 spikeYing Fu, Juliana da Fonseca Rezende E Mello, Bryan D Fleming, et al.
Biorxiv : the Preprint Server for Biology|November 3, 2021
A humanized nanobody phage display library yields potent binders of SARS CoV-2 spikeYing Fu, Juliana da Fonseca Rezende E Mello, Bryan D Fleming, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 29, 2014
High-throughput combinatorial screening identifies drugs that cooperate with ibrutinib to kill activated B-cell-like diffuse large B-cell lymphoma cellsLesley A Mathews Griner, Rajarshi Guha, Paul Shinn, et al.
Pageof 44